Membrane Trafficking Laboratory at Candiolo Cancer Institute - FPO, IRCCS, Candiolo, Italy.
Department of Oncology, University of Turin Medical School, Turin, Italy.
Cancer Res. 2017 Apr 15;77(8):1813-1817. doi: 10.1158/0008-5472.CAN-16-3403. Epub 2017 Apr 3.
Alterations of endo/exocytic proteins have long been associated with malignant transformation, and genes encoding membrane trafficking proteins have been identified as drivers of tumorigenesis. Focusing on the mechanisms underlying the impact of endo/exocytic proteins in cancer, a scenario emerges in which altered trafficking routes/networks appear to be preferentially involved in the acquisition of prometastatic traits. This involvement in metastasis frequently occurs through the integration of programs leading to migratory/invasive phenotypes, survival and resistance to environmental stresses, epithelial-to-mesenchymal transition, and the emergence of cancer stem cells. These findings might have important implications in the clinical setting for the development of metastasis-specific drugs and for patient stratification to optimize the use of available therapies. .
内吞/外排蛋白的改变一直与恶性转化有关,编码膜转运蛋白的基因已被确定为肿瘤发生的驱动因素。关注内吞/外排蛋白在癌症中影响的机制,出现了一种情况,即改变的运输途径/网络似乎优先参与获得促转移特性。这种对转移的参与通常是通过整合导致迁移/侵袭表型、生存和对环境压力的抵抗、上皮-间充质转化以及癌症干细胞出现的程序来实现的。这些发现可能对临床环境中开发针对转移的特异性药物以及对患者进行分层以优化现有治疗方法的应用具有重要意义。